Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Hepatology (Baltimore, Md.)
|
May 13, 2017
Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen
Edward J Gane, Mitchell L Shiffman, Kyle Etzkorn, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 20, 2024
Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBD
Batul Kaj-Carbaidwala, Johan Fevery, Douglas G Adler, et al.
International Journal of Astrobiology
|
December 4, 2023
Astrovirology: how viruses enhance our understanding of life in the Universe
Gareth Trubl, Kenneth M Stedman, Kathryn F Bywaters, et al.
Lancet (London, England)
|
October 19, 2010
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
Edward J Gane, Stuart K Roberts, Catherine A M Stedman, et al.
Microbiology Resource Announcements
|
September 5, 2020
Best Practices for Successfully Writing and Publishing a Genome Announcement in <i>Microbiology Resource Announcements</i>
Julie C Dunning Hotopp, David A Baltrus, Vincent M Bruno, et al.
Annals of Internal Medicine
|
November 10, 2015
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial
Stephen Pianko, Steven L Flamm, Mitchell L Shiffman, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
A geothermal amoeba sets a new upper temperature limit for eukaryotes
H Beryl Rappaport, Natalie A Petek-Seoane, Tomáš Tyml, et al.
Gastroenterology
|
August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial
Edward J Gane, Kris V Kowdley, David Pound, et al.
Mbio
|
September 3, 2020
Unveiling Crucivirus Diversity by Mining Metagenomic Data
Ignacio de la Higuera, George W Kasun, Ellis L Torrance, et al.
The New England Journal of Medicine
|
July 22, 2015
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Susanna Naggie, Curtis Cooper, Michael Saag, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Hepatology (Baltimore, Md.)
|
May 13, 2017
Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen
Edward J Gane, Mitchell L Shiffman, Kyle Etzkorn, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 20, 2024
Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBD
Batul Kaj-Carbaidwala, Johan Fevery, Douglas G Adler, et al.
International Journal of Astrobiology
|
December 4, 2023
Astrovirology: how viruses enhance our understanding of life in the Universe
Gareth Trubl, Kenneth M Stedman, Kathryn F Bywaters, et al.
Lancet (London, England)
|
October 19, 2010
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
Edward J Gane, Stuart K Roberts, Catherine A M Stedman, et al.
Microbiology Resource Announcements
|
September 5, 2020
Best Practices for Successfully Writing and Publishing a Genome Announcement in <i>Microbiology Resource Announcements</i>
Julie C Dunning Hotopp, David A Baltrus, Vincent M Bruno, et al.
Annals of Internal Medicine
|
November 10, 2015
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial
Stephen Pianko, Steven L Flamm, Mitchell L Shiffman, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
A geothermal amoeba sets a new upper temperature limit for eukaryotes
H Beryl Rappaport, Natalie A Petek-Seoane, Tomáš Tyml, et al.
Gastroenterology
|
August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial
Edward J Gane, Kris V Kowdley, David Pound, et al.
Mbio
|
September 3, 2020
Unveiling Crucivirus Diversity by Mining Metagenomic Data
Ignacio de la Higuera, George W Kasun, Ellis L Torrance, et al.
The New England Journal of Medicine
|
July 22, 2015
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Susanna Naggie, Curtis Cooper, Michael Saag, et al.
Page
of 13